| Poornima U Hegde, MD | |
|
263 Farmington Ave, Farmington, CT 06030-0001 | |
| (860) 679-2980 | |
| (860) 679-4334 |
| Full Name | Poornima U Hegde |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 39 Years |
| Location | 263 Farmington Ave, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386640589 | NPI | - | NPPES |
| 1407586 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 040758 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Dempsey Hospital | Farmington, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Connecticut Health Center | 3678472016 | 523 |
News Archive
Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread.
The American College of Radiology (ACR) Radiology Leadership Institute (RLI) has awarded scholarships to 10 residents enabling them to attend the RLI Annual Event, July 25-28, 2013, at the Kellogg School of Management on Northwestern University's Evanston, IL, campus.
A Food and Drug Administration (FDA) panel yesterday recommended the approval of Orexigen Therapeutics' weight loss drug Contrave. This is the first time a weight loss drug has received the nod. The vote went 13 to 7 for Contrave's approval and 11 to 8, with an abstention that additional studies be conducted on heart risks. Although experts agree to risks they believe the benefits outweigh the risks. Although the FDA is not compelled to go with the panel's recommendation, it more often than not does. The FDA will deliver its verdict by Jan. 31 2011.
The environmental concern is great when considering the role of toxic contaminants in the plant-soil relationship. Understanding plant's absorption and accumulation of these contaminants from the soil would be incredibly beneficial.
Veterans of the war in Vietnam, the Gulf War, Somalia, Iraq, and Afghanistan suffering from post-traumatic stress disorder found significant relief from their symptoms as a result of practicing the Transcendental Meditation technique, according to a new study published in Military Medicine.
› Verified 2 days ago
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread.
The American College of Radiology (ACR) Radiology Leadership Institute (RLI) has awarded scholarships to 10 residents enabling them to attend the RLI Annual Event, July 25-28, 2013, at the Kellogg School of Management on Northwestern University's Evanston, IL, campus.
A Food and Drug Administration (FDA) panel yesterday recommended the approval of Orexigen Therapeutics' weight loss drug Contrave. This is the first time a weight loss drug has received the nod. The vote went 13 to 7 for Contrave's approval and 11 to 8, with an abstention that additional studies be conducted on heart risks. Although experts agree to risks they believe the benefits outweigh the risks. Although the FDA is not compelled to go with the panel's recommendation, it more often than not does. The FDA will deliver its verdict by Jan. 31 2011.
The environmental concern is great when considering the role of toxic contaminants in the plant-soil relationship. Understanding plant's absorption and accumulation of these contaminants from the soil would be incredibly beneficial.
Veterans of the war in Vietnam, the Gulf War, Somalia, Iraq, and Afghanistan suffering from post-traumatic stress disorder found significant relief from their symptoms as a result of practicing the Transcendental Meditation technique, according to a new study published in Military Medicine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Poornima U Hegde, MD 263 Farmington Ave, Provider Enrollment, Farmington, CT 06030-2212 Ph: (860) 679-7503 | Poornima U Hegde, MD 263 Farmington Ave, Farmington, CT 06030-0001 Ph: (860) 679-2980 |
News Archive
Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread.
The American College of Radiology (ACR) Radiology Leadership Institute (RLI) has awarded scholarships to 10 residents enabling them to attend the RLI Annual Event, July 25-28, 2013, at the Kellogg School of Management on Northwestern University's Evanston, IL, campus.
A Food and Drug Administration (FDA) panel yesterday recommended the approval of Orexigen Therapeutics' weight loss drug Contrave. This is the first time a weight loss drug has received the nod. The vote went 13 to 7 for Contrave's approval and 11 to 8, with an abstention that additional studies be conducted on heart risks. Although experts agree to risks they believe the benefits outweigh the risks. Although the FDA is not compelled to go with the panel's recommendation, it more often than not does. The FDA will deliver its verdict by Jan. 31 2011.
The environmental concern is great when considering the role of toxic contaminants in the plant-soil relationship. Understanding plant's absorption and accumulation of these contaminants from the soil would be incredibly beneficial.
Veterans of the war in Vietnam, the Gulf War, Somalia, Iraq, and Afghanistan suffering from post-traumatic stress disorder found significant relief from their symptoms as a result of practicing the Transcendental Meditation technique, according to a new study published in Military Medicine.
› Verified 2 days ago
Dr. Maryam J Zenali, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 | |
Dr. Christopher Alan Wallace, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 270 Farmington Avenue, Suite 332, Farmington, CT 06089 Phone: 888-276-2223 Fax: 972-767-0225 | |
Dollett Tanisha White, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 11 Shuttle Rd, Farmington, CT 06032 Phone: 860-679-3980 | |
Esma Ersoy, MD Pathology Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 | |
Margaret Grunnet, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 | |
Christina Stanley, Pathology Medicare: Not Enrolled in Medicare Practice Location: 11 Shuttle Rd, Farmington, CT 06032 Phone: 860-679-1076 | |
Qian Wu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 |